Danncy Vainilla Recall: The firm's vanilla product contains coumarin, a prohibited substance.
United States
TerminatedClass II
- Company
- Danncy Vainilla
- Product
- Danncy Vainilla Pure Mexican Vanilla Extract Clear Gluten Fr…
- Recall date
- February 5, 2023
- Terminated
- April 3, 2024
- Source
- FDA
Reason for recall
The firm's vanilla product contains coumarin, a prohibited substance.
- - Recall initiated
- - Reported by source
- - Recall terminated
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| Danncy Vainilla Pure Mexican Vanilla Extract Clear Gluten Free Produced by Juan Miguel Anzaldua Gutierrez NET 33.8 FL OZ (1.0L) UPC 7503000781137 packaged in clear plastic bottles and Danncy Vainilla Pure Mexican Vanilla Extract Gluten Free Produced by Juan Miguel Anzaldua Gutierrez NET 33.8 FL OZ (1.0L) UPC 7503000781106 packaged in clear plastic bottles | 7503000781137 | ~1,542 boxes | All Danncy Vanilla Products |
Distribution
- Texas and California
Official source record
- Agency
- FDA
- Dataset
- FDA Food Enforcement (Recalls)
- Recall number
- F-0688-2023
- Event ID
- 91573
- Status
- Terminated
- Classification
- Class II
- Company
- Danncy Vainilla
- Product description
- Danncy Vainilla Pure Mexican Vanilla Extract Clear Gluten Free Produced by Juan Miguel Anzaldua Gutierrez NET 33.8 FL OZ (1.0L) UPC 7503000781137 packaged in clear plastic bottles and Danncy Vainilla Pure Mexican Vanilla Extract Gluten Free Produced by Juan Miguel Anzaldua Gutierrez NET 33.8 FL OZ (1.0L) UPC 7503000781106 packaged in clear plastic bottles
- Quantity
- ~1,542 boxes
- Reason
- The firm's vanilla product contains coumarin, a prohibited substance.
- Recall initiation date
- February 5, 2023
- Report date
- April 5, 2023
- Classification date
- Not published in this source record
- Termination date
- April 3, 2024
- Distribution pattern
- Texas and California
- UPC, lot, and code information
- UPC 7503000781137; All Danncy Vanilla Products
- Voluntary or mandated
- Voluntary: Firm initiated
- Initial notification method
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Source last updated
- Not tracked separately from the Public Health Trace retrieval date below
- Public Health Trace retrieval date
Responsible company: Danncy Vainilla
Where this information comes from
View FDA enforcement record -- the specific openFDA record this summary was built from.
No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
Technical source data
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
Frequently asked questions
What does a Class II mean?
A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.
Is this recall still active?
According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
What should I do if I have this product?
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
Where can I find more official information?
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.
